Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
Department of Microbiology, New York University School of Medicine, New York, New York, USA.
J Virol. 2022 Jun 22;96(12):e0050822. doi: 10.1128/jvi.00508-22. Epub 2022 May 24.
Understanding the molecular mechanisms of herpes simplex virus 1 (HSV-1) latent infection and reactivation in neurons requires the use of model systems. Establishing a quiescent infection in cultured neurons is problematic, as any infectious virus released can superinfect the cultures. Previous studies have used the viral DNA replication inhibitor acyclovir to prevent superinfection and promote latency establishment. Data from these previous models have shown that reactivation is biphasic, with an initial phase I expression of all classes of lytic genes, which occurs independently of histone demethylase activity and viral DNA replication but is dependent on the cell stress protein DLK. Here, we describe a new model system using HSV-1 Stayput-GFP, a reporter virus that is defective for cell-to-cell spread and establishes latent infections without the need for acyclovir. The establishment of a latent state requires a longer time frame than previous models using DNA replication inhibitors. This results in a decreased ability of the virus to reactivate using established inducers, and as such, a combination of reactivation triggers is required. Using this system, we demonstrate that biphasic reactivation occurs even when latency is established in the absence of acyclovir. Importantly, phase I lytic gene expression still occurs in a histone demethylase and viral DNA replication-independent manner and requires DLK activity. These data demonstrate that the two waves of viral gene expression following HSV-1 reactivation are independent of secondary infection and not unique to systems that require acyclovir to promote latency establishment. Herpes simplex virus-1 (HSV-1) enters a latent infection in neurons and periodically reactivates. Reactivation manifests as a variety of clinical symptoms. Studying latency and reactivation is invaluable, allowing the molecular mechanisms behind both processes to be targeted by therapeutics that reduce the clinical consequences. Here, we describe a novel model system using a cell-to-cell spread-defective HSV-1, known as Stayput-GFP, which allows for the study of latency and reactivation at the single neuron level. We anticipate this new model system will be an incredibly valuable tool for studying the establishment and reactivation of HSV-1 latent infection . Using this model, we find that initial reactivation events are dependent on cellular stress kinase DLK but independent of histone demethylase activity and viral DNA replication. Our data therefore further validate the essential role of DLK in mediating a wave of lytic gene expression unique to reactivation.
理解单纯疱疹病毒 1 (HSV-1) 在神经元中潜伏感染和再激活的分子机制需要使用模型系统。在培养的神经元中建立静止感染是有问题的,因为释放的任何传染性病毒都可能再次感染培养物。以前的研究使用病毒 DNA 复制抑制剂阿昔洛韦来防止再次感染并促进潜伏建立。这些先前模型的数据表明,再激活是两相的,所有裂解基因的类初始 I 期表达,这独立于组蛋白去甲基化酶活性和病毒 DNA 复制,但依赖于细胞应激蛋白 DLK。在这里,我们描述了一个使用 HSV-1 Stayput-GFP 的新模型系统,该报告病毒对细胞间传播有缺陷,并且在不需要阿昔洛韦的情况下建立潜伏感染。潜伏状态的建立需要比以前使用 DNA 复制抑制剂的模型更长的时间框架。这导致病毒使用已建立的诱导剂重新激活的能力降低,因此需要组合使用多种再激活触发剂。使用该系统,我们证明即使在没有阿昔洛韦的情况下建立潜伏状态,也会发生两相再激活。重要的是,I 期裂解基因表达仍然以组蛋白去甲基化酶和病毒 DNA 复制独立的方式发生,并且需要 DLK 活性。这些数据表明,HSV-1 再激活后两种病毒基因表达波是独立于二次感染的,并且不仅仅存在于需要阿昔洛韦来促进潜伏建立的系统中。单纯疱疹病毒-1 (HSV-1) 在神经元中进入潜伏感染并定期再激活。再激活表现为各种临床症状。研究潜伏和再激活对于治疗减少临床后果至关重要,它使两种过程背后的分子机制都成为靶向治疗的目标。在这里,我们描述了一种使用细胞间传播缺陷型 HSV-1 的新型模型系统,称为 Stayput-GFP,它允许在单个神经元水平上研究潜伏和再激活。我们预计这个新的模型系统将成为研究 HSV-1 潜伏感染建立和再激活的极其有价值的工具。使用该模型,我们发现初始再激活事件依赖于细胞应激激酶 DLK,但独立于组蛋白去甲基化酶活性和病毒 DNA 复制。因此,我们的数据进一步验证了 DLK 在介导再激活特有的一波裂解基因表达中的关键作用。